Literature DB >> 23015678

Optimizing the management of prostate cancer in senior adults: call to action.

John M Fitzpatrick1.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23015678      PMCID： PMC3593778          DOI： 10.1634/theoncologist.2012-S1-01

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


× No keyword cloud information.
  19 in total

1.  Patient and treatment factors associated with complications after prostate brachytherapy.

Authors:  Aileen B Chen; Anthony V D'Amico; Bridget A Neville; Craig C Earle
Journal:  J Clin Oncol       Date:  2006-11-20       Impact factor: 44.544

2.  Guideline for the management of clinically localized prostate cancer: 2007 update.

Authors:  Ian Thompson; James Brantley Thrasher; Gunnar Aus; Arthur L Burnett; Edith D Canby-Hagino; Michael S Cookson; Anthony V D'Amico; Roger R Dmochowski; David T Eton; Jeffrey D Forman; S Larry Goldenberg; Javier Hernandez; Celestia S Higano; Stephen R Kraus; Judd W Moul; Catherine M Tangen
Journal:  J Urol       Date:  2007-06       Impact factor: 7.450

3.  Undernutrition in elderly patients with cancer: target for diagnosis and intervention.

Authors:  Christèle Blanc-Bisson; Marianne Fonck; Muriel Rainfray; Pierre Soubeyran; Isabelle Bourdel-Marchasson
Journal:  Crit Rev Oncol Hematol       Date:  2008-06-12       Impact factor: 6.312

4.  A brief clinical instrument to classify frailty in elderly people.

Authors:  K Rockwood; K Stadnyk; C MacKnight; I McDowell; R Hébert; D B Hogan
Journal:  Lancet       Date:  1999-01-16       Impact factor: 79.321

5.  Deaths: final data for 2008.

Authors:  Arialdi M Miniño; Sherry L Murphy; Jiaquan Xu; Kenneth D Kochanek
Journal:  Natl Vital Stat Rep       Date:  2011-12-07

6.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

7.  Cancer screening in elderly patients: a framework for individualized decision making.

Authors:  L C Walter; K E Covinsky
Journal:  JAMA       Date:  2001-06-06       Impact factor: 56.272

8.  20-year outcomes following conservative management of clinically localized prostate cancer.

Authors:  Peter C Albertsen; James A Hanley; Judith Fine
Journal:  JAMA       Date:  2005-05-04       Impact factor: 56.272

9.  Greater influence of age than co-morbidity on primary treatment and complications of prostate cancer patients: an in-depth population-based study.

Authors:  S Houterman; M L G Janssen-Heijnen; C D G W Verheij; P J M Kil; H A van den Berg; J W Coebergh
Journal:  Prostate Cancer Prostatic Dis       Date:  2006-03-14       Impact factor: 5.554

10.  Long-term survival probability in men with clinically localized prostate cancer: a case-control, propensity modeling study stratified by race, age, treatment and comorbidities.

Authors:  Ashutosh Tewari; Christine Cole Johnson; George Divine; E David Crawford; Eduard J Gamito; Raymond Demers; Mani Menon
Journal:  J Urol       Date:  2004-04       Impact factor: 7.450
View more
  2 in total

Review 1.  Perspectives on treatment of metastatic castration-resistant prostate cancer.

Authors:  Axel S Merseburger; Joaquim Bellmunt; Cheryl Jenkins; Chris Parker; John M Fitzpatrick
Journal:  Oncologist       Date:  2013-05-13

2.  Population-based study on use of chemotherapy in men with castration resistant prostate cancer.

Authors:  Ingela Franck Lissbrant; Hans Garmo; Anders Widmark; Pär Stattin
Journal:  Acta Oncol       Date:  2013-02-21       Impact factor: 4.089
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.